Contents

Current Drug Therapy, Volume 2 - Number 3

Tardive Dyskinesia with Atypical Antipsychotic Drugs

, 2(3): 168 - 176

Jambur Ananth, Kartik Ananth and Aparna Keshavan


DOI: 10.2174/157488507781695630




The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?

, 2(3): 177 - 195

Giovanni Anfossi and Mariella Trovati


DOI: 10.2174/157488507781695676




Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus

, 2(3): 196 - 204

Rumi Ghosh, Vaidehi Thanawala and Vilasrao J. Kadam


DOI: 10.2174/157488507781695658




Ion Exchange Resins: A Novel Way to Solve Formulation Problems

, 2(3): 205 - 209

Kisan R. Jadhav, Meenakshi Chandra, Sushma D. Kurm and Vilasrao J. Kadam


DOI: 10.2174/157488507781695694




Pharmacokinetic and Pharmacodynamic Profiles of Rapid-Acting Artemisinins in the Antimalarial Therapy

, 2(3): 210 - 223

Qigui Li, Peter J. Weina and Wilbur K. Milhous


DOI: 10.2174/157488507781695649




Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma

, 2(3): 224 - 232

Toshiyuki Oshitari and Sayon Roy


DOI: 10.2174/157488507781695685




Study on Caspase-Induced Mitochondrial Dysfunction by Anticancer Drugs

, 2(3): 233 - 235

Zhimin Tao, Matthew P. Morrow, Harvey S. Penefsky, Jerry Goodisman and Abdul-Kader Souid


DOI: 10.2174/157488507781695621




Aliskiren: A Novel Renin Inhibitor for Hypertension

, 2(3): 236 - 239

Vandana Tayal and Bhupinder Singh Kalra


DOI: 10.2174/157488507781695667




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science